New registry maps how targeted liver treatment is used in colorectal cancer
NCT ID NCT03086096
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This registry followed 152 patients with colorectal cancer that had spread mainly to the liver. Doctors used tiny beads called LifePearl Microspheres loaded with the chemotherapy drug irinotecan, delivered directly to the liver's blood supply. The goal was to see how and when this treatment is used in real-world practice, and to track safety and survival.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
LifePearl Microspheres loaded with Irinotecan
What this could lead to
If the results are positive, this could help doctors better understand when and how to use this liver-directed treatment for colorectal cancer that has spread to the liver.
What could go wrong
This is an observational registry, not a controlled trial, so it cannot prove the treatment works better than other options. Results may vary widely between patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLORECTAL CARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CIRSE Cardiovascular and Interventional Radiological Society of Europe
Vienna, State of Vienna, 1010, Austria